Cargando…

Macht ADHS vulnerabler gegenüber SARS-CoV-2?

Detalles Bibliográficos
Autor principal: M. Heim, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204603/
http://dx.doi.org/10.1007/s15005-021-2006-5
_version_ 1783708370052579328
author M. Heim, Thomas
author_facet M. Heim, Thomas
author_sort M. Heim, Thomas
collection PubMed
description
format Online
Article
Text
id pubmed-8204603
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-82046032021-06-15 Macht ADHS vulnerabler gegenüber SARS-CoV-2? M. Heim, Thomas InFo Neurologie Aktuell Springer Medizin 2021-06-25 2021 /pmc/articles/PMC8204603/ http://dx.doi.org/10.1007/s15005-021-2006-5 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Aktuell
M. Heim, Thomas
Macht ADHS vulnerabler gegenüber SARS-CoV-2?
title Macht ADHS vulnerabler gegenüber SARS-CoV-2?
title_full Macht ADHS vulnerabler gegenüber SARS-CoV-2?
title_fullStr Macht ADHS vulnerabler gegenüber SARS-CoV-2?
title_full_unstemmed Macht ADHS vulnerabler gegenüber SARS-CoV-2?
title_short Macht ADHS vulnerabler gegenüber SARS-CoV-2?
title_sort macht adhs vulnerabler gegenüber sars-cov-2?
topic Aktuell
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204603/
http://dx.doi.org/10.1007/s15005-021-2006-5
work_keys_str_mv AT mheimthomas machtadhsvulnerablergegenubersarscov2